Hypercalcemia may also reduce the calcemic effect of PTH, which may benefit secondary hyperparathyroidism.[33] Finally, patients with high PTH levels may have a wider normal range of serum Ca levels because only hyperphosphatemia and the Ca-P product can predict mortality [34]. This evidence concerns the gene PTH and hyperphosphatemia.